NCT03063658

Brief Summary

This study will evaluate two different analgesic regimen used for acute postoperative pain.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
108

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Feb 2017

Longer than P75 for phase_4

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

February 21, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 24, 2017

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2021

Completed
Last Updated

July 8, 2019

Status Verified

July 1, 2019

Enrollment Period

3.7 years

First QC Date

February 21, 2017

Last Update Submit

July 4, 2019

Conditions

Keywords

IbuprofenParacetamolLaparoscopic cholecystectomyMorphineVisual analog scale

Outcome Measures

Primary Outcomes (1)

  • Morphine consumption

    Total morphine consumption during the 24 hours of early postoperative period

    The first 24 hours after the completion of the surgery

Secondary Outcomes (2)

  • VAS scores

    The first 24 hours after the completion of the surgery

  • Morphine side effects

    The first 24 hours after the completion of the surgery

Study Arms (2)

Paracetamol

ACTIVE COMPARATOR

Paracetamol (Paracerol) 1 gram will be administered intravenously. The first dose will be infused for 10 minutes after the induction of anesthesia and before the first surgical incision. The remaining three doses will be administered every 6 hours for postoperative 24 hours.

Drug: Paracetamol

Ibuprofen

ACTIVE COMPARATOR

Ibuprofen (Intrafen) 800 mg will be administered intravenously. The first dose will be infused for 10 minutes after the induction of anesthesia and before the first surgical incision. The remaining three doses will be administered every 6 hours for postoperative 24 hours.

Drug: Ibuprofen 800 mg

Interventions

The first dose of 1 gr intravenous paracetamol will be administered preoperatively and the remaining three doses will be given each six hours in the early postoperative period.

Paracetamol

The first dose of 800 mg intravenous ibuprofen will be administered preoperatively and the remaining three doses will be given each six hours in the early postoperative period.

Ibuprofen

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologist Functional Status 1-2
  • Body mass index smaller than 30
  • Undergoing laparoscopic cholecystectomy
  • Age between 18-60 years

You may not qualify if:

  • Age under 18, above 60
  • Weight under 40 kg
  • Body mass index above 30
  • Contraindication for opioid and non-steroid anti-inflammatory drug usage
  • Allergy against paracetamol, opioids and anti-inflammatory drugs
  • Peptic ulcer
  • Tendency to bleeding
  • Pregnancy or breast feeding
  • Moderate or severe renal, hepatic or cardiac insufficiency
  • Coronary artery disease
  • Asthma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ankara University Faculty of Medicine

Ankara, 06100, Turkey (Türkiye)

ACTIVE NOT RECRUITING

Ankara University School of Medicine

Ankara, 06660, Turkey (Türkiye)

RECRUITING

Related Publications (3)

  • Singla N, Rock A, Pavliv L. A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen (IV-ibuprofen) for treatment of pain in post-operative orthopedic adult patients. Pain Med. 2010 Aug;11(8):1284-93. doi: 10.1111/j.1526-4637.2010.00896.x. Epub 2010 Jun 30.

    PMID: 20609131BACKGROUND
  • Gago Martinez A, Escontrela Rodriguez B, Planas Roca A, Martinez Ruiz A. Intravenous Ibuprofen for Treatment of Post-Operative Pain: A Multicenter, Double Blind, Placebo-Controlled, Randomized Clinical Trial. PLoS One. 2016 May 6;11(5):e0154004. doi: 10.1371/journal.pone.0154004. eCollection 2016.

    PMID: 27152748BACKGROUND
  • Gan TJ, Candiotti K, Turan A, Buvanendran A, Philip BK, Viscusi ER, Soghomonyan S, Bergese SD; Intravenous Ibuprofen Surgical Surveillance Trial Investigational Sites. The shortened infusion time of intravenous ibuprofen, part 2: a multicenter, open-label, surgical surveillance trial to evaluate safety. Clin Ther. 2015 Feb 1;37(2):368-75. doi: 10.1016/j.clinthera.2014.12.006. Epub 2015 Jan 13.

    PMID: 25592331BACKGROUND

MeSH Terms

Conditions

Acute PainPain, Postoperative

Interventions

AcetaminophenIbuprofen

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic Processes

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesPhenylpropionatesAcids, CarbocyclicCarboxylic Acids

Study Officials

  • Zekeriyya Alanoglu, Professor

    Ankara University Department of Anesthesiology and Intensive Care Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Menekse Ozcelik, M.D

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D

Study Record Dates

First Submitted

February 21, 2017

First Posted

February 24, 2017

Study Start

February 1, 2017

Primary Completion

October 31, 2020

Study Completion

May 31, 2021

Last Updated

July 8, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations